0.1 andr syrota
DESCRIPTION
TRANSCRIPT
3rd International Biomedical Research Meeting
June 10th 2011
Résidence de Marigny
Pr André Syrota
The French Alliance for Life and Health Sciences: Aviesan
Created in April 2009
To optimise scientific foresight and put forward scientific programming to Funding Agencies
To facilitate the development of top-level clusters and research centers
To promote national projects and to set up national core facilities
2
• Research operating agencies :• Inserm • CNRS life sciences department• CEA (atomic energy commission)• Inra (national institute for agricultural research)• Inria (computer science and automatic control)• IRD (research for development)• Pasteur Institute
• Universities• Hospitals
Ten Thematic Institutes covering the entire field of Life and health Sciences
NeurosciencesCognitive Sciences
Neurology, Psychiatry
Genetics, Genomics
Bioinformatics
ImmunologyHematologyRespiratory
diseases
MicrobiologyInfectiousdiseases
PublicHealth
HealthTechnologies
3
Cancer
Cell Biology
Development
Molecular and
Structural Biology
Nutrition
Circulation
Metabolism
Keywords: Sharing a common strategy to ensure an improved coordination
« Epidemiologie France » : a new internet portal for health research
• A web catalog of major health databases from French sources that may be useful to improve research and public health expertise
• This catalog contains descriptions of 237 databases including 130 cohort studies, 76 industrial studies and 31 morbidity registries
• A standardized description form for each database describes the main features: aims, population, methods, acces modes, responsible of the database
• Search engine and browse tools allows the visitor to explore the on line catalog in three ways: browse, simple and advanced search
• English version under construction
http://epidemiologie-france.fr
35 billion €
21.9 devoted to Research and Higher education
Investments for the future : a major opportunity for boosting R&I
• CANTO (breast cancer) : Institut Gustave Roussy / Inserm• OFSEP (multiple sclerosis) : Université Claude Bernard Lyon 1 / Hospices
civils de Lyon / Inserm• RADICO (rare diseases) : Inserm• i-SHARE (relationship between behaviour or exposure and pathogenesis
among young adults) : Université de Bordeaux / Inserm / Université de Versailles Saint Quentin
• E4N (genetics and biological risk factors) : Institut Gustave Roussy / Inserm• HOPE-EPI (pediatric cancers) : Inserm• CKD-REIN (chronic renal insufficiency) : Université Paris Sud 11• CRYOSTEM (transplant rejection and leukemia) : Société Française de
Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)• COBLAnce (bladder cancer) : Inserm• Psy-COH (chronic psychiatric disorders) : Fondation FondaMental
10 cohorts
70 millions € for 10 years
• BIOBANQUES (public health, biomarkers), coordination Inserm• F- CRIN (clinical research), coordination Inserm• HIDDEN (biosafety level 4 laboratory), Inserm • France-BioImaging (cell imaging), coordination CNRS• FRISBI (structural biology), coordination CNRS• PHENOMIN (phenotyping), coordination CNRS• ProFI (proteomics), coordination CNRS• France Génomique (genomics), coordination CEA• EMBRC-France (marine biology), université Pierre et Marie Curie, CNRS
9 national research infrastructures for biology and health
220 millions € for 10 years
• Neurosciences (Paris)• Cardiometabolism and nutrition (Paris)• Genetic diseases (Paris) • Cardiology (Bordeaux)• Surgery (Strasbourg)• Infectious diseases (Marseille)
6 university hospitals
« Instituts hospitalo-universitaires »
350 millions € for 10 years
10
www.aviesan.fr